{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:20:09Z","timestamp":1788574809077,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM38765"],"award-info":[{"award-number":["R01GM38765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM139430"],"award-info":[{"award-number":["R35GM139430"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bcp.2022.115181","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:29:12Z","timestamp":1657945752000},"page":"115181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A newly synthesized 17-epi-NeuroProtectin D1\/17-epi-Protectin D1: Authentication and functional regulation of Inflammation-Resolution"],"prefix":"10.1016","volume":"203","author":[{"given":"Kajal","family":"Hamidzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Westcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wourms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nshimiyimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Serhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2022.115181_b0005","doi-asserted-by":"crossref","first-page":"nzac011","DOI":"10.1093\/cdn\/nzac011","article-title":"A Systematic Review of the Impact of the First Year of COVID-19 on Obesity Risk Factors: A Pandemic Fueling a Pandemic?","volume":"6","author":"Daniels","year":"2022","journal-title":"Curr Dev Nutr"},{"issue":"7503","key":"10.1016\/j.bcp.2022.115181_b0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2022.115181_b0015","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstrom","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2022.115181_b0020","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2022.115181_b0025","first-page":"397","article-title":"Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome","volume":"2015","author":"Serhan","year":"1851","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2022.115181_b0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2022.115181_b0035","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2022.115181_b0040","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"J. Immunol."},{"issue":"7146","key":"10.1016\/j.bcp.2022.115181_b0045","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2022.115181_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2015.10.002","article-title":"Dihydroxylated E,E,Z-docosatrienes. An overview of their synthesis and biological significance","volume":"61","author":"Balas","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"12","key":"10.1016\/j.bcp.2022.115181_b0055","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1039\/D0OB02136A","article-title":"A new synthetic protectin D1 analog 3-oxa-PD1(n-3 DPA) reduces neuropathic pain and chronic itch in mice","volume":"19","author":"Nesman","year":"2021","journal-title":"Org Biomol Chem"},{"issue":"6","key":"10.1016\/j.bcp.2022.115181_b0060","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1021\/jo500147r","article-title":"Total synthesis of neuroprotectin D1 analogues derived from omega-6 docosapentaenoic acid (DPA) and adrenic acid (AdA) from a common pivotal, late-stage intermediate","volume":"79","author":"Dayaker","year":"2014","journal-title":"J. Org. Chem."},{"issue":"36","key":"10.1016\/j.bcp.2022.115181_b0065","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1039\/C8OB01232F","article-title":"Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents","volume":"16","author":"Tungen","year":"2018","journal-title":"Org Biomol Chem"},{"issue":"14","key":"10.1016\/j.bcp.2022.115181_b0070","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.tetlet.2012.01.032","article-title":"Stereocontrolled total synthesis of neuroprotectin D1 \/ protectin D1 and its aspirin-triggered stereoisomer","volume":"53","author":"Petasis","year":"2012","journal-title":"Tetrahedron Lett."},{"issue":"2","key":"10.1016\/j.bcp.2022.115181_b0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2012.07.048","article-title":"Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma","volume":"131","author":"Miyata","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115181_b0080","doi-asserted-by":"crossref","first-page":"C1058","DOI":"10.1152\/ajpcell.00270.2014","article-title":"Neuroprotectin\/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes","volume":"307","author":"Hong","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bcp.2022.115181_b0085","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2022.115181_b0090","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1523\/JNEUROSCI.2443-11.2011","article-title":"Resolving TRPV1 and TNF-\u03b1-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2022.115181_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107883","article-title":"Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation","volume":"98","author":"Park","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.bcp.2022.115181_b0100","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1002\/lary.29337","article-title":"Neuroprotectin D1 Attenuates Blast Overpressure Induced Reactive Microglial Cells in the Cochlea","volume":"131","author":"R\u00edos","year":"2021","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.bcp.2022.115181_b0105","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1167\/iovs.13-12152","article-title":"Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology","volume":"54","author":"Rajasagi","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115181_b0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2013.02.027","article-title":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza","volume":"153","author":"Morita","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2022.115181_b0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbalip.2015.01.006","article-title":"Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection","volume":"1851","author":"Imai","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"17","key":"10.1016\/j.bcp.2022.115181_b0120","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1111\/bph.15156","article-title":"Pro-resolving mediator protectin D1 promotes epimorphic regeneration by controlling immune cell function in vertebrates","volume":"177","author":"Nguyen\u2010Chi","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"22","key":"10.1016\/j.bcp.2022.115181_b0125","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/acs.biochem.0c00931","article-title":"In Vitro Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2","volume":"60","author":"Tsai","year":"2021","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.bcp.2022.115181_b0130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel proresolving aspirin-triggered DHA pathway","volume":"18","author":"Serhan","year":"2011","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115181_b0135","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41467-018-03674-2","article-title":"Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease","volume":"9","author":"Lee","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.bcp.2022.115181_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.582674","article-title":"Neuroprotectin D1 Protects Against Postoperative Delirium-Like Behavior in Aged Mice","volume":"12","author":"Zhou","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"51","key":"10.1016\/j.bcp.2022.115181_b0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116559118","article-title":"Human leukocytes selectively convert 4S,5S-epoxy-Resolvin to Resolvin D3, Resolvin D4, and a cys-Resolvin isomer","volume":"118","author":"Shay","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bcp.2022.115181_b0150","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation-resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2022.115181_b0155","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2022.115181_b0160","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1021\/acs.jnatprod.5b00574","article-title":"Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages","volume":"78","author":"Aursnes","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bcp.2022.115181_b0165","series-title":"Robbins Pathologic Basis of Disease","author":"Cotran","year":"1999"},{"issue":"1","key":"10.1016\/j.bcp.2022.115181_b0170","first-page":"32","article-title":"Hematologic and serum biochemical reference values in nontransgenic FVB mice","volume":"50","author":"Schneck","year":"2000","journal-title":"Comp Med"},{"issue":"3","key":"10.1016\/j.bcp.2022.115181_b0175","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/mi.2015.99","article-title":"Human milk proresolving mediators stimulate resolution of acute inflammation","volume":"9","author":"Arnardottir","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bcp.2022.115181_b0180","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3389\/fimmu.2020.01307","article-title":"Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation","volume":"11","author":"Ferguson","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.bcp.2022.115181_b0185","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1038\/s41598-021-82606-5","article-title":"Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults","volume":"11","author":"Terrando","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2022.115181_b0190","article-title":"Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease","author":"Do","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2022.115181_b0195","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.1800806","article-title":"Cutting Edge: Human vagus produces specialized pro-resolving mediators of inflammation with electrical stimulation reducing pro-inflammatory eicosanoids","volume":"201","author":"Serhan","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115181_b0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s42003-022-03169-3","article-title":"Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in App(NL-G-F\/NL-G-F) mice","volume":"5","author":"Emre","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.bcp.2022.115181_b0205","doi-asserted-by":"crossref","first-page":"22847","DOI":"10.1074\/jbc.M603766200","article-title":"Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions","volume":"281","author":"Arita","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115181_b0210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2012.04.007","article-title":"Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke","volume":"236","author":"Bazan","year":"2012","journal-title":"Exp. Neurol."},{"issue":"21","key":"10.1016\/j.bcp.2022.115181_b0215","doi-asserted-by":"crossref","first-page":"9961","DOI":"10.1021\/acs.jmedchem.9b01463","article-title":"Rapid Metabolization of Protectin D1 by \u03b2-Oxidation of Its Polar Head Chain","volume":"62","author":"Balas","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2022.115181_b0220","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/all.14595","article-title":"Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19","volume":"76","author":"Andreakos","year":"2021","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.bcp.2022.115181_b0225","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2022.115181_b0230","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41467-021-21940-8","article-title":"Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice","volume":"12","author":"Bang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bcp.2022.115181_b0235","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3389\/fmicb.2019.01826","article-title":"Pseudomonas aeruginosa Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid Signaling","volume":"10","author":"Morello","year":"2019","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.bcp.2022.115181_b0240","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/acs.biochem.5b01378","article-title":"Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry","volume":"55","author":"Lucido","year":"2016","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.bcp.2022.115181_b0245","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5756","key":"10.1016\/j.bcp.2022.115181_b0250","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1126\/science.1119407","article-title":"Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2","volume":"310","author":"Kim","year":"2005","journal-title":"Science"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222002751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222002751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:38:20Z","timestamp":1757770700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222002751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":50,"alternative-id":["S0006295222002751"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115181","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A newly synthesized 17-epi-NeuroProtectin D1\/17-epi-Protectin D1: Authentication and functional regulation of Inflammation-Resolution","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115181"}}